JP2025507962A - 炎症性腸疾患の治療のためのgpr120アゴニスト - Google Patents
炎症性腸疾患の治療のためのgpr120アゴニスト Download PDFInfo
- Publication number
- JP2025507962A JP2025507962A JP2024552421A JP2024552421A JP2025507962A JP 2025507962 A JP2025507962 A JP 2025507962A JP 2024552421 A JP2024552421 A JP 2024552421A JP 2024552421 A JP2024552421 A JP 2024552421A JP 2025507962 A JP2025507962 A JP 2025507962A
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- gpr120
- sulfamoyl
- heptanoic acid
- gpr120 agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22160079.4 | 2022-03-03 | ||
| EP22160079.4A EP4238557A1 (en) | 2022-03-03 | 2022-03-03 | Gpr120 agonists for the treatment of inflammatory bowel disease |
| PCT/EP2023/055490 WO2023166203A1 (en) | 2022-03-03 | 2023-03-03 | Gpr120 agonists for the treatment of inflammatory bowel disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507962A true JP2025507962A (ja) | 2025-03-21 |
| JP2025507962A5 JP2025507962A5 (cg-RX-API-DMAC10.html) | 2026-02-10 |
Family
ID=80628869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552421A Pending JP2025507962A (ja) | 2022-03-03 | 2023-03-03 | 炎症性腸疾患の治療のためのgpr120アゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250177329A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4238557A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025507962A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119031908A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3248186A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL314689A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023166203A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120919101A (zh) * | 2025-09-26 | 2025-11-11 | 南京农业大学 | Gw9508在制备治疗轮状病毒的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3281937A1 (en) * | 2016-08-09 | 2018-02-14 | Dompé farmaceutici S.p.A. | Sulfonamides as gpr40- and gpr120-agonists |
| CN111317728A (zh) * | 2018-12-14 | 2020-06-23 | 中国科学院大连化学物理研究所 | 天然来源ffa4(gpr120)受体激动剂及其应用 |
-
2022
- 2022-03-03 EP EP22160079.4A patent/EP4238557A1/en not_active Withdrawn
-
2023
- 2023-03-03 EP EP23708797.8A patent/EP4486327A1/en active Pending
- 2023-03-03 WO PCT/EP2023/055490 patent/WO2023166203A1/en not_active Ceased
- 2023-03-03 CN CN202380023191.0A patent/CN119031908A/zh active Pending
- 2023-03-03 US US18/843,373 patent/US20250177329A1/en active Pending
- 2023-03-03 IL IL314689A patent/IL314689A/en unknown
- 2023-03-03 JP JP2024552421A patent/JP2025507962A/ja active Pending
- 2023-03-03 CA CA3248186A patent/CA3248186A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4486327A1 (en) | 2025-01-08 |
| EP4238557A1 (en) | 2023-09-06 |
| WO2023166203A1 (en) | 2023-09-07 |
| CN119031908A (zh) | 2024-11-26 |
| CA3248186A1 (en) | 2023-09-07 |
| US20250177329A1 (en) | 2025-06-05 |
| IL314689A (en) | 2024-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI432201B (zh) | 11-去氧基-前列腺素化合物用於治療週邊血管疾病之用途 | |
| AU2026200298A1 (en) | Pharmaceutical use of an extended-release composition containing pirfenidone for the treatment and reversal of human steatohepatitis (nafld/nash) | |
| JPH04504726A (ja) | アナフィラキシーの遅反応性物質に対する拮抗薬としてのリポキシンa↓4およびその誘導体の使用 | |
| KR20210100594A (ko) | 염증성 장애의 치료에 사용하기 위한 벤조이미다졸 유도체 | |
| WO2016112875A2 (zh) | 二联苯衍生物及其应用 | |
| KR102694423B1 (ko) | 신규한 글루타미닐 고리화효소 억제제 및 다양한 질환의 치료에서의 이의 용도 | |
| US20250177329A1 (en) | Gpr120 agonists for the treatment of inflammatory bowel disease | |
| JP2019077615A (ja) | 非アルコール性脂肪性肝疾患/非アルコール性脂肪性肝炎の治療剤 | |
| SU1297865A1 (ru) | Способ лечени больных хроническим неспецифическим звенным колитом | |
| CN105147703B (zh) | 黄柏酮在制备防治溃疡性结肠炎的药物中的应用 | |
| JPH1017478A (ja) | 潰瘍性大腸炎の予防又は治療剤 | |
| JP2008509899A (ja) | 胃腸管の炎症性疾患治療用の細胞特異的コンジュゲートの使用 | |
| CN105147661B (zh) | 升麻素在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| RU2829636C1 (ru) | Фармацевтическая композиция на основе 5-пентилрезорцинола для лечения воспалительных заболеваний кишечника | |
| CN105079012A (zh) | 天麻素在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| CN112107564A (zh) | 五味子醇甲在制备防治溃疡性结肠炎的药物中的应用 | |
| CN111991387A (zh) | 去氢二异丁香酚在制备防治溃疡性结肠炎的药物中的应用 | |
| BR112012000410B1 (pt) | uso de benzidamina ou dos sais de adição de ácido, e, composição farmacêutica | |
| JP5753435B2 (ja) | 抗潰瘍剤組成物 | |
| FR3090317A1 (fr) | Utilisation d’un antagoniste de par-1 pour le traitement d’une maladie inflammatoire chronique intestinale | |
| RU2690372C2 (ru) | Лекарственные средства, содержащие диацереин, и способы снижения уровней мочевой кислоты в крови с его использованием | |
| CN119405649A (zh) | 呋喃二烯酮在制备治疗炎症性肠病药物中的应用 | |
| JP6090723B2 (ja) | 腎機能障害の予防又は改善剤 | |
| IT201900019858A1 (it) | Composizione farmaceutica comprendente una combinazione sinergica di ibuprofene e N-acetilcisteina | |
| WO2022006278A1 (en) | Reducing fibrosis and treating related diseases, disorders, and conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260202 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20260202 |